Standard BioTools Inc.
LAB
$1.07
-$0.11-9.32%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.89% | 20.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.89% | 20.87% | |||
| Cost of Revenue | 14.30% | -47.72% | |||
| Gross Profit | -5.83% | 639.20% | |||
| SG&A Expenses | 9.26% | -3.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.38% | -10.38% | |||
| Operating Income | -22.38% | 39.39% | |||
| Income Before Tax | -26.03% | 41.27% | |||
| Income Tax Expenses | 130.51% | 114.55% | |||
| Earnings from Continuing Operations | -26.48% | 41.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.48% | 41.08% | |||
| EBIT | -22.38% | 39.39% | |||
| EBITDA | -43.81% | 49.76% | |||
| EPS Basic | -25.52% | 40.96% | |||
| Normalized Basic EPS | -57.36% | 44.84% | |||
| EPS Diluted | -25.52% | 40.96% | |||
| Normalized Diluted EPS | -57.36% | 44.84% | |||
| Average Basic Shares Outstanding | 0.81% | -0.21% | |||
| Average Diluted Shares Outstanding | 0.81% | -0.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
